Full name
KRAJMED CENTRUM NOWOCZESNEJ LARYNGOLOGII SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
KRAJMED CENTRUM NOWOCZESNEJ LARYNGOLOGII SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. JANA SEBASTIANA BACHA 2, 02-743 WARSZAWA
TAX ID5252558572
Rate company:
KRAJMED CENTRUM NOWOCZESNEJ LARYNGOLOGII SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID5252558572
KRS0000468012
Share capital5,000.00 zł
address
UL. JANA SEBASTIANA BACHA 2, 02-743 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5252558572
REGON
146771299
KRS
0000468012
Legal form
limited liability company
Register Address
UL. JANA SEBASTIANA BACHA 2, 02-743 WARSZAWA
Date of registration in KRS
2013-07-05
Date of commencement of economic activity
2013-07-05
Act signature
WA.XIII NS-REJ.KRS/35956/22/304/ADE
Pkd codes
86.22.Z - Specialist medical practice
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.74.Z - Retail sale of medical and orthopedic products
64.19.Z - Other monetary intermediation
64.92.Z - Other forms of credit granting
86.10.Z - Hospital activities
86.21.Z - General medical practice
86.90.E - Healthcare
Payer VAT status
exempted
Vat list bank account(s)
PL64 1090 1694 0000 0001 2348 5248 
PL10 1090 1694 0000 0001 2382 4265 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets  | 9,9 | 8,8 | 6,7 | -23,7 |
Gross profit (loss) | 0,4 | 1,5 | 2,5 | 64,6 |
EBITDA | 3,7 | 3,7 | 5,1 | 37,3 |
Net profit (loss) | 0,4 | 1,5 | 2,4 | 59,7 |
Cash | 0,6 | 0,4 | 0,5 | 16,4 |
Liabilities and provisions for liabilities | 8,8 | 6,8 | 2,4 | -65,5 |
Net income from sale | 14,7 | 14,7 | 22,9 | 55,6 |
Short time liabilities | 1,2 | 1,4 | 1,2 | -13,5 |
Equity capital | 1,2 | 1,9 | 4,3 | 123,3 |
Working assets | 1,4 | 1,7 | 1,9 | 11,3 |
Operating profit (EBIT) | 0,9 | 1,6 | 2,5 | 52 |
Depreciation | 2,8 | 2,1 | 2,6 | 25,7 |
% | % | % | p.p. | |
Profitability of capital | 38,1 | 77,2 | 55,2 | -22 |
Equity capital to total assets | 11,8 | 22,2 | 64,8 | 42,6 |
Gross profit margin | 3 | 10,2 | 10,8 | 0,6 |
EBITDA Margin | 25,3 | 25,2 | 22,2 | -3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 30 | 34 | 19 | -15 |
Financial statements
01-01-2022 - 30-09-2022
Annual financial report
Download xml01-01-2022 - 30-09-2022
Annual financial report
Download pdf01-01-2022 - 30-09-2022
Activity report
Download docx01-01-2022 - 30-09-2022
Resolution or decision approving the annual financial statements
Download docx01-10-2022 - 30-09-2023
Annual financial report
Download xml01-10-2022 - 30-09-2023
Annual financial report
Download pdf01-10-2022 - 30-09-2023
Activity report
Download docx01-10-2022 - 30-09-2023
Resolution or decision approving the annual financial statements
Download docxShow more (5)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.